Abstract

Background Dry eye is a multifactor disease which needs comprehensive treatments to keep the homeostasis of ocular surface. Objective To explore the effect of hypochlorous acid on the meibomian gland dysfunction dry eye through ultrasonic atomization. Methods We set this study of 0.01% HOCL and 0.1% hyaluronate by ultrasonic atomization. All the data was recorded at the 1st, 15th, 30th, and 55th days. The patients' complains, the meibum analysis, conjunctive congestion, corneal staining, Schirmer's I test, and NIBUT were recorded by K5M, the MMP-9, and IL-2 of tear by inflammation kit; the Demodex was recorded by microscopy. Results 53 patients have joined this study. There is no statistic difference between them on OSDI (day 15: p = 0.061, 30: p = 0.055, 55: p = 0.052); results show the 10.57 ± 0.13 and 12.54 ± 0.17 reduction on OSDI; the differences of both treatments are significant (∗∗p < 0.01). Increased Schirmer's and TBUT are 3.27 ± 0.10 and 6.29 ± 0.10 (∗∗p < 0.01) or 7.32 ± 1.72 s and 9.22 ± 1.41 s (∗p < 0.05); the decreased conjunctive and corneal staining are 0.23 ± 0.07 and 0.45 ± 0.06 (∗∗p < 0.01) or 0.42 ± 0.03 and 0.37 ± 0.02 (∗p < 0.05) at both groups. The differences of MMP-9 and IL-2 negative rate are significant (Z = 0.896, ∗∗p = 0.002 < 0.01; Z = 0.659, ∗∗p = 0.001 < 0.01); the number of Demodex mites at first is 10 or 11, while the last is 2 or 6 (Z = −4.642, ∗∗p < 0.01; Z = 2.742, p > 0.05). The Demodex count between them is significant (Z = −2.310, ∗p = 0.032 < 0.05). The survival times (ST) of each stage at the HOCL are 110.75 (108.50 ± 24.50), 95.50 (90.25 ± 14.50), and 75.25 (73.48 ± 8.50) min which are shorter than those of control which are 155.50 (160.10 ± 21.50), 130.25 (128.25 ± 16.50), and 105.75 (102.50 ± 14.50) min (∗∗p < 0.01). The Demodex eradication rate of HOCL is statistic significant (∗p15th vs. 1stday = 0.028 < 0.05; ∗∗p30th vs. 1stday = 0.002 < 0.01; ∗∗p55th vs. 1stday = 0.0018 < 0.01). Conclusions 0.01% HOCL improves the Demodex eradication by shortening the survival time; the HOCL acts on the ocular surface by reducing the inflammation. The ultrasonic atomization helps for the drug usage.

Highlights

  • The patients’ complains, the meibum analysis, conjunctive congestion, corneal staining, Schirmer’s I test, and NIBUT were recorded by Keratograph® 5M (K5M), the matrix metalloproteinase-9 (MMP-9), and IL-2 of tear by inflammation kit; the Demodex was recorded by microscopy

  • The Dry Eye Work Shop (DEWS) II (2017) report has rewritten the dry eye disease (DED) definition: “Dry eye is a multifactorial ocular surface disease characterized by loss of tear film homeostasis associated ocular symptoms, in which tear film instability and hyperosmolarity, inflammation and ocular surface lesions, as well as neurosensory abnormalities play etiologic roles” [1]

  • MMP-9 and IL-2 levels were measured at the beginning and last of the study in the tears’ components of the recruiter by the Inflammation Dry® test. 16 subjects out of 27 (59.26%) from the Hypochlorous acid (HOCL) group and 16 subjects out of 26 (61.54%) from the placebo groups demonstrate MMP-9-positive results in the left eye at the 1st day

Read more

Summary

Introduction

The Dry Eye Work Shop (DEWS) II (2017) report has rewritten the dry eye disease (DED) definition: “Dry eye is a multifactorial ocular surface disease characterized by loss of tear film homeostasis associated ocular symptoms, in which tear film instability and hyperosmolarity, inflammation and ocular surface lesions, as well as neurosensory abnormalities play etiologic roles” [1]. The study of 619 randomly chosen participants from a population-based study in north China; 8.6% were symptomatic MGD while the asymptomatic MGD rate was 21.9% [6] Many of these ocular clinical manifestations interweave with dry eye, and Demodex relative MGD is believed to be the key pathological factor to evaporative induced dry eye [7]. To explore the effect of hypochlorous acid on the meibomian gland dysfunction dry eye through ultrasonic atomization. There is no statistic difference between them on OSDI (day 15: p = 0:061, 30: p = 0:055, 55: p = 0:052); results show the 10:57 ± 0:13 and 12:54 ± 0:17 reduction on OSDI; the differences of both treatments are significant (∗∗p < 0:01). The Demodex eradication rate of HOCL is statistic significant (∗p15th vs 1stday = 0:028 < 0:05; ∗∗p30th vs 1stday = 0:002 < 0:01; ∗∗p55th vs 1stday = 0:0018 < 0:01).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call